FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2182575939> ?p ?o ?g. }

• W2182575939 endingPage "1287" @default.
• W2182575939 startingPage "1285" @default.
• W2182575939 abstract "Patients' perceptions are vital to the delivery and evaluation of substance use treatment. They are most frequently collected at one time-point and measured using patient satisfaction questionnaires or qualitative methodologies. Interestingly, the findings of these studies often diverge, as satisfaction scores tend to be highly positive, while qualitative findings suggest dissatisfaction and areas for improvement. This divergence limits current understandings of patients' perceptions and their potential change over time in treatment.This study explores the relationship between open-ended positive and negative perceptions of treatment and patient satisfaction scores over time.The RUTH (Research on the Utilization of Therapeutic Hydromorphone) prospective cohort study included 131 participants receiving injectable diacetylmorphine or hydromorphone in Canada's first injectable opioid agonist treatment (iOAT) program. The study collected the Client Satisfaction Questionnaire (CSQ-8) at eight time-points over an 18-month period. Following a multi-methods approach, the study complemented the CSQ-8 with open-ended positive and negative comments of iOAT. The research team analyzed these comments thematically at each time-point to develop positive and negative perception themes. We then used growth curve modeling to explore the relationship between positive and negative perception themes and patient satisfaction over time.Over the eight time-points, six positive and eight negative perception themes emerged, broadly reflecting structural (e.g., expansion of iOAT), process (e.g., schedules), relational (e.g., interactions with providers), and outcome-related (e.g., met/unmet needs) perceptions of iOAT. On average, participants reported high satisfaction (grand mean = 29.2 out of 32), and scores did not significantly change over time. However, we did find significant unexplained variation within participants in their satisfaction trajectories and between participants in their initial satisfaction scores. In conditional growth curve models, the theme “unfavorable interactions with providers” had the strongest independent effect on overall satisfaction trajectories.This study provides an example of how open-ended comments can be integrated with patient satisfaction questionnaire data to gather a comprehensive and patient-centered evaluation of substance use treatment. Considering the iOAT context specifically, relational dynamics and daily treatment access were significant predictors of patient satisfaction over time and may be attributes of iOAT that require further investigation." @default.
• W2182575939 created "2016-06-24" @default.
• W2182575939 creator A5014505953 @default.
• W2182575939 creator A5015390785 @default.
• W2182575939 creator A5043766967 @default.
• W2182575939 creator A5043939930 @default.
• W2182575939 creator A5058641711 @default.
• W2182575939 date "2015-12-01" @default.
• W2182575939 modified "2023-10-10" @default.
• W2182575939 title "Towards a genuinely user-centred evaluation of harm reduction and drug treatment programmes: A further proposal" @default.
• W2182575939 cites W1483899396 @default.
• W2182575939 cites W1782810126 @default.
• W2182575939 cites W1903506133 @default.
• W2182575939 cites W1969408843 @default.
• W2182575939 cites W2021186354 @default.
• W2182575939 cites W2024694542 @default.
• W2182575939 cites W2033340053 @default.
• W2182575939 cites W2057072674 @default.
• W2182575939 cites W2063117479 @default.
• W2182575939 cites W2075635531 @default.
• W2182575939 cites W2087771377 @default.
• W2182575939 cites W2091174979 @default.
• W2182575939 cites W2100889218 @default.
• W2182575939 cites W2106736493 @default.
• W2182575939 cites W2107188916 @default.
• W2182575939 cites W2110832498 @default.
• W2182575939 cites W2114204524 @default.
• W2182575939 cites W2118451280 @default.
• W2182575939 cites W2128536774 @default.
• W2182575939 cites W2139474630 @default.
• W2182575939 cites W2150100475 @default.
• W2182575939 cites W2161340142 @default.
• W2182575939 cites W2161701044 @default.
• W2182575939 cites W2168184373 @default.
• W2182575939 cites W2547933991 @default.
• W2182575939 doi "https://doi.org/10.1016/j.drugpo.2015.08.012" @default.
• W2182575939 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26372296" @default.
• W2182575939 hasPublicationYear "2015" @default.
• W2182575939 type Work @default.
• W2182575939 sameAs 2182575939 @default.
• W2182575939 citedByCount "11" @default.
• W2182575939 countsByYear W21825759392016 @default.
• W2182575939 countsByYear W21825759392017 @default.
• W2182575939 countsByYear W21825759392018 @default.
• W2182575939 countsByYear W21825759392019 @default.
• W2182575939 countsByYear W21825759392020 @default.
• W2182575939 countsByYear W21825759392022 @default.
• W2182575939 countsByYear W21825759392023 @default.
• W2182575939 crossrefType "journal-article" @default.
• W2182575939 hasAuthorship W2182575939A5014505953 @default.
• W2182575939 hasAuthorship W2182575939A5015390785 @default.
• W2182575939 hasAuthorship W2182575939A5043766967 @default.
• W2182575939 hasAuthorship W2182575939A5043939930 @default.
• W2182575939 hasAuthorship W2182575939A5058641711 @default.
• W2182575939 hasConcept C126322002 @default.
• W2182575939 hasConcept C138816342 @default.
• W2182575939 hasConcept C144024400 @default.
• W2182575939 hasConcept C15744967 @default.
• W2182575939 hasConcept C159110408 @default.
• W2182575939 hasConcept C169760540 @default.
• W2182575939 hasConcept C170493617 @default.
• W2182575939 hasConcept C190248442 @default.
• W2182575939 hasConcept C26760741 @default.
• W2182575939 hasConcept C2775944032 @default.
• W2182575939 hasConcept C2777363581 @default.
• W2182575939 hasConcept C2779158186 @default.
• W2182575939 hasConcept C2781063702 @default.
• W2182575939 hasConcept C36289849 @default.
• W2182575939 hasConcept C529928208 @default.
• W2182575939 hasConcept C70410870 @default.
• W2182575939 hasConcept C71924100 @default.
• W2182575939 hasConcept C77805123 @default.
• W2182575939 hasConceptScore W2182575939C126322002 @default.
• W2182575939 hasConceptScore W2182575939C138816342 @default.
• W2182575939 hasConceptScore W2182575939C144024400 @default.
• W2182575939 hasConceptScore W2182575939C15744967 @default.
• W2182575939 hasConceptScore W2182575939C159110408 @default.
• W2182575939 hasConceptScore W2182575939C169760540 @default.
• W2182575939 hasConceptScore W2182575939C170493617 @default.
• W2182575939 hasConceptScore W2182575939C190248442 @default.
• W2182575939 hasConceptScore W2182575939C26760741 @default.
• W2182575939 hasConceptScore W2182575939C2775944032 @default.
• W2182575939 hasConceptScore W2182575939C2777363581 @default.
• W2182575939 hasConceptScore W2182575939C2779158186 @default.
• W2182575939 hasConceptScore W2182575939C2781063702 @default.
• W2182575939 hasConceptScore W2182575939C36289849 @default.
• W2182575939 hasConceptScore W2182575939C529928208 @default.
• W2182575939 hasConceptScore W2182575939C70410870 @default.
• W2182575939 hasConceptScore W2182575939C71924100 @default.
• W2182575939 hasConceptScore W2182575939C77805123 @default.
• W2182575939 hasIssue "12" @default.
• W2182575939 hasLocation W21825759391 @default.
• W2182575939 hasLocation W21825759392 @default.
• W2182575939 hasOpenAccess W2182575939 @default.
• W2182575939 hasPrimaryLocation W21825759391 @default.
• W2182575939 hasRelatedWork W144150090 @default.
• W2182575939 hasRelatedWork W2011223819 @default.
• W2182575939 hasRelatedWork W2029317765 @default.

• next